Recombinant Xenopus laevis Guanine nucleotide-binding protein-like 3 (gnl3), partial

Shipped with Ice Packs
In Stock

Product Specs

Form
Lyophilized powder
Note: While we prioritize shipping the format currently in stock, please specify your format preference in order notes for customized preparation.
Lead Time
Delivery times vary depending on the purchase method and location. Contact your local distributor for precise delivery estimates.
Note: Standard shipping includes blue ice packs. Dry ice shipping requires prior arrangement and incurs additional charges.
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Centrifuge the vial briefly before opening to consolidate the contents. Reconstitute the protein in sterile, deionized water to a concentration of 0.1-1.0 mg/mL. For long-term storage, we recommend adding 5-50% glycerol (final concentration) and aliquoting at -20°C/-80°C. Our standard glycerol concentration is 50% and can serve as a reference.
Shelf Life
Shelf life depends on storage conditions, buffer composition, temperature, and protein stability. Generally, liquid formulations have a 6-month shelf life at -20°C/-80°C, while lyophilized formulations have a 12-month shelf life at -20°C/-80°C.
Storage Condition
Upon receipt, store at -20°C/-80°C. Aliquot for multiple uses to prevent repeated freeze-thaw cycles.
Tag Info
Tag type is determined during manufacturing.
The tag type is determined during production. Specify your required tag type for preferential development.
Synonyms
gnl3Guanine nucleotide-binding protein-like 3; Nucleostemin-like protein
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Protein Length
Partial
Purity
>85% (SDS-PAGE)
Species
Xenopus laevis (African clawed frog)
Target Names
gnl3
Uniprot No.

Target Background

Function
May play a regulatory role in cellular proliferation.
Gene References Into Functions
  1. Nucleostemin regulates cell proliferation in neural progenitor cells during early amphibian development. PMID: 17000755
Database Links

KEGG: xla:380340

UniGene: Xl.4873

Protein Families
TRAFAC class YlqF/YawG GTPase family
Subcellular Location
Nucleus. Nucleus, nucleolus.

Q&A

What is GNL3 and what are its primary functions in Xenopus laevis?

GNL3 (Guanine nucleotide-binding protein-like 3) is an evolutionarily conserved stem cell gene that plays crucial roles in cell proliferation, animal growth, regeneration, and sexual reproduction . In vertebrates like Xenopus laevis, GNL3 functions are fundamentally similar to those observed in other species, particularly in stem cell maintenance and cell division regulation. Research has demonstrated that GNL3 shows high conservation across species, with invertebrate GNL3 sequences (including those from model organisms) sharing significant similarity with vertebrate GNL3L proteins . The protein contains specific functional domains that are essential for its nucleolar localization and interaction with other cellular components involved in proliferation pathways.

How does Xenopus laevis serve as a model organism for GNL3 research?

Xenopus laevis has become a model of choice for biological research since it was discovered that it could easily be induced to breed in laboratory settings by injecting human gonadotrophin . Its phylogenetic position as an amphibian places it intermediately between aquatic vertebrates and land tetrapods, making it valuable for evolutionary studies. For GNL3 research specifically, Xenopus offers several advantages: its embryos develop externally and are large enough for manipulation; its genome has been sequenced; and transgenic techniques are well-established for this species . The University of Rochester maintains comprehensive resources for Xenopus laevis research, including genetically-defined inbred strains and clones, as well as research tools such as transgenic animals, monoclonal antibodies, cell lines, DNA libraries, and molecular probes .

How can I determine GNL3 expression patterns in Xenopus laevis tissues?

To determine GNL3 expression patterns in Xenopus laevis tissues, researchers typically employ in situ hybridization (ISH) techniques similar to those used in other model organisms. Studies examining GNL3 expression in other species have successfully utilized fluorescent in situ hybridization (FISH) to co-localize GNL3 with stem cell markers like Piwi1 . For Xenopus specifically, you would design RNA probes complementary to Xenopus laevis GNL3 transcripts. The protocol involves tissue fixation, permeabilization, hybridization with labeled probes, and visualization using fluorescence microscopy. To validate expression patterns, researchers often combine ISH with immunohistochemistry using antibodies against GNL3 or with EdU labeling to identify proliferating cells, as GNL3 expression correlates strongly with cell proliferation markers in various species .

What is the relationship between GNL3 expression and immune system development in Xenopus laevis?

The relationship between GNL3 expression and immune system development in Xenopus laevis represents an intriguing research area that merits further investigation. Xenopus laevis possesses an immune system fundamentally similar to mammals, with a thymus, spleen, and distinct T and B lymphocytes expressing somatically generated receptors . Given that GNL3 functions as a critical regulator of stem cell proliferation and cell cycle progression across species , it likely plays important roles in hematopoietic stem cell maintenance and immune cell development in Xenopus. Studies in mammalian systems have implicated GNL3 in hematopoietic stem cell self-renewal, suggesting that similar mechanisms may be conserved in amphibians. To investigate this relationship, researchers should analyze GNL3 expression in thymic tissue, spleen, and circulating blood cells at different developmental stages, particularly during metamorphosis when significant immune system remodeling occurs. Functional studies using stage-specific GNL3 knockdown could help elucidate its role in immune cell development and function.

What techniques are available for generating transgenic Xenopus laevis models to study GNL3 function?

Generating transgenic Xenopus laevis models to study GNL3 function can be accomplished through several established methods, with the restriction enzyme-mediated integration (REMI) approach being particularly effective. This three-part protocol involves: 1) isolating sperm nuclei from adult X. laevis testis by treatment with lysolecithin to permeabilize the sperm plasma membrane; 2) preparing egg extract through centrifugation and calcium addition to progress to interphase; and 3) combining nuclei and extract with linearized plasmid DNA containing the GNL3 construct and a small amount of restriction enzyme . The egg extract partially decondenses the sperm chromatin while the restriction enzyme generates chromosomal breaks that facilitate transgene recombination into the genome. The treated sperm nuclei are then transplanted into unfertilized eggs, resulting in non-chimeric embryos with stable integration of the transgene .

For GNL3-specific studies, researchers can design constructs with fluorescent tags for visualizing protein localization or with inducible promoters for temporal control over GNL3 expression. Alternative approaches include CRISPR/Cas9 genome editing for targeted modifications of the endogenous GNL3 locus, which allows for precise gene knockout or knock-in studies. For transient expression studies, mRNA microinjection into early embryos provides a more straightforward approach, though integration is not stable across generations.

How can I optimize RNA interference experiments to study GNL3 function in Xenopus laevis?

Optimizing RNA interference (RNAi) experiments to study GNL3 function in Xenopus laevis requires careful consideration of several technical parameters. Based on successful RNAi approaches in other model organisms, such as the shRNA-mediated knockdown of GNL3 in Hydractinia , researchers should first design multiple shRNA or siRNA sequences targeting different regions of Xenopus laevis GNL3 mRNA to ensure specificity and efficiency. These sequences should be validated bioinformatically to minimize off-target effects by confirming they don't match other transcripts in the Xenopus genome.

For delivery, microinjection of synthesized RNAi molecules into early embryos (1-4 cell stage) is typically most effective in Xenopus. Studies in Hydractinia used shRNA electroporation at a concentration of 1500 ng/μl, which proved more effective than lower concentrations (900 ng/μl) . For Xenopus experiments, researchers should test a concentration gradient (e.g., 500-2000 ng/μl) to determine optimal knockdown efficiency while minimizing toxicity. Include appropriate controls such as scrambled sequences verified not to target any Xenopus genes, and confirm knockdown efficiency through qPCR and Western blotting. Monitor phenotypic effects by assessing developmental progression, cell proliferation (using EdU labeling and phospho-histone H3 immunostaining), and expression of stem cell markers (e.g., Piwi1) .

What analytical methods are most effective for characterizing GNL3 protein interactions in Xenopus laevis cells?

For characterizing GNL3 protein interactions in Xenopus laevis cells, multiple complementary analytical methods should be employed to ensure comprehensive and reliable results. Co-immunoprecipitation (Co-IP) coupled with mass spectrometry represents the foundation of protein interaction studies. This approach involves using antibodies specific to Xenopus GNL3 to pull down the protein along with its binding partners from cell lysates, followed by mass spectrometric identification of the co-precipitated proteins. Given that GNL3 has demonstrated evolutionary conservation in its function across species , researchers should particularly focus on validating interactions with proteins involved in ribosome biogenesis, cell cycle regulation, and pluripotency networks.

Proximity-based labeling techniques such as BioID or APEX2 offer advantages for detecting transient or weak interactions. These methods involve fusing GNL3 to a biotin ligase that biotinylates proteins in close proximity, allowing subsequent purification and identification of neighboring proteins regardless of interaction strength. For visualizing interactions in situ, proximity ligation assay (PLA) or fluorescence resonance energy transfer (FRET) microscopy can be employed in Xenopus cell cultures or tissue sections. Yeast two-hybrid screening specifically using Xenopus laevis cDNA libraries can further expand the identification of potential interacting partners. To validate the functional significance of identified interactions, researchers should perform domain mapping through deletion mutants and assess the impact of disrupting specific interactions on cell proliferation, stem cell maintenance, and developmental processes.

How can recombinant Xenopus laevis GNL3 be utilized in immunological research?

Recombinant Xenopus laevis GNL3 can serve as a valuable tool in immunological research, particularly given the established role of Xenopus as an important model organism for studying immune system evolution and function . The University of Rochester houses a comprehensive resource for Xenopus laevis immunobiological research, providing access to genetically-defined strains and research tools that facilitate such studies . Recombinant GNL3 protein can be used to generate specific antibodies for immunohistochemistry, flow cytometry, and Western blot analyses to track endogenous GNL3 expression in immune cells during development and immune responses.

Since GNL3 functions as a critical regulator of cell proliferation across species , it likely plays important roles in immune cell proliferation and differentiation. Researchers can use purified recombinant GNL3 to investigate its effects on lymphocyte proliferation in ex vivo cultures of Xenopus immune cells. Additionally, the protein can be employed in structure-function studies to identify domains that interact with immune-related signaling molecules. This research is particularly valuable because Xenopus occupies a phylogenetically intermediate position between aquatic vertebrates and land tetrapods, making it ideal for comparative immunological studies that distinguish species-specific adaptations from conserved features of the immune system .

What role does GNL3 play in Xenopus laevis regeneration, and how can this inform regenerative medicine research?

While the search results don't provide direct evidence of GNL3's role in Xenopus laevis regeneration specifically, comparative studies in other organisms strongly suggest its importance in regenerative processes. In Hydractinia, GNL3 knockdown resulted in polyps with impaired regeneration capabilities , indicating a conserved function in tissue renewal that likely extends to amphibians like Xenopus, which are known for their remarkable regenerative abilities. Given that GNL3 regulates cell proliferation and is expressed in stem cell populations , it likely contributes to Xenopus regeneration by mediating the proliferative response of progenitor cells required for tissue replacement.

To investigate this role, researchers could employ transgenic approaches in Xenopus to modulate GNL3 expression during tadpole tail or limb regeneration, using techniques such as the restriction enzyme-mediated integration described earlier . Time-course studies examining GNL3 expression during different phases of regeneration, combined with gain- and loss-of-function experiments, would reveal its temporal requirements during the regenerative process. These findings could inform regenerative medicine by identifying conserved molecular mechanisms that govern vertebrate tissue regeneration. Since Xenopus represents an evolutionarily intermediate position between aquatic vertebrates and mammals , discoveries regarding GNL3's regenerative functions could bridge fundamental insights from lower vertebrates to potential therapeutic applications in human medicine.

How does GNL3 expression correlate with microbial interactions in Xenopus laevis skin?

The relationship between GNL3 expression and microbial interactions in Xenopus laevis skin represents an emerging research direction with implications for both fundamental biology and conservation efforts. Recent studies have shown that probiotic colonization of Xenopus laevis skin by bacterial strains (including Pseudomonas and Stenotrophomonas species) causes significant alterations to resident microbial communities and host immune responses . While direct evidence linking GNL3 to these interactions is not provided in the search results, GNL3's established role in cell proliferation suggests it may influence epithelial renewal and immune cell function in skin tissues exposed to microbiota.

To investigate this correlation, researchers could analyze GNL3 expression in Xenopus skin before and after exposure to probiotic bacteria using RT-qPCR and immunohistochemistry. This could be combined with 16S rRNA gene sequencing to characterize microbial community changes, similar to the approach described in recent studies . Of particular interest would be examining whether GNL3 expression in skin stem cells changes in response to microbial colonization, and whether these changes correlate with altered immune markers. Such research would contribute to understanding how host stem cell regulators like GNL3 participate in maintaining skin barrier function and regulating host-microbe interactions, with potential applications in addressing amphibian diseases such as chytridiomycosis .

How does Xenopus laevis GNL3 compare structurally and functionally to GNL3 in other vertebrate and invertebrate species?

Functionally, GNL3 maintains core roles in cell proliferation, growth regulation, and stem cell maintenance across species . The protein contains conserved functional domains essential for nucleolar localization and GTP binding/hydrolysis. In vertebrates like Xenopus, GNL3 likely regulates ribosome biogenesis and interacts with p53 pathways to control cell cycle progression, similar to its mammalian counterparts. Importantly, experimental evidence from Hydractinia demonstrates that GNL3 knockdown reduces cell proliferation and mitotic activity without affecting stem cell numbers , suggesting a conserved role in regulating cell cycle rather than stem cell identity across evolutionarily distant species. This functional conservation makes Xenopus GNL3 valuable for studying fundamental aspects of stem cell biology and proliferation control relevant to multiple species, including humans.

What insights can transgenic Xenopus models provide about the evolutionary conservation of GNL3 function?

Transgenic Xenopus models offer unique advantages for investigating the evolutionary conservation of GNL3 function across vertebrate lineages. The stable integration of cloned gene products into the Xenopus genome using techniques like restriction enzyme-mediated integration (REMI) enables precise control over the timing and location of gene expression. This allows researchers to test whether GNL3 from different species can functionally substitute for the endogenous Xenopus protein through cross-species rescue experiments.

For evolutionary studies, researchers could generate transgenic Xenopus lines expressing GNL3 orthologs from diverse vertebrate and invertebrate species under the control of the endogenous Xenopus GNL3 promoter after knocking out the native gene. The ability of these orthologs to rescue developmental, proliferative, or regenerative phenotypes would provide direct evidence for functional conservation. Additionally, domain-swapping experiments using chimeric proteins containing regions from different species' GNL3 could identify which domains have evolved specialized functions versus those that maintain ancestral roles.

These approaches are particularly powerful in Xenopus because transgenic embryos can be analyzed without breeding to the next generation , allowing rapid assessment of evolutionary hypotheses. Furthermore, since Xenopus occupies an intermediate phylogenetic position between aquatic vertebrates and land tetrapods , findings regarding GNL3 conservation in this model can bridge understanding between fish and mammalian systems, providing insights into vertebrate evolution that would be difficult to obtain from other models.

What are the current limitations in studying GNL3 function in Xenopus laevis, and how might they be addressed?

Current limitations in studying GNL3 function in Xenopus laevis include technical challenges and knowledge gaps that require innovative approaches. One significant limitation is the evolutionary tetraploidization of the Xenopus laevis genome, which often results in gene duplications that can complicate genetic manipulation and functional analysis. For GNL3 specifically, researchers must contend with potential redundancy between paralogs that may mask phenotypes in single-gene knockdown experiments. To address this, comprehensive CRISPR/Cas9 targeting of all GNL3 homologs simultaneously would be necessary, followed by careful validation of knockout efficiency at both RNA and protein levels.

Another limitation concerns the availability of Xenopus-specific reagents such as antibodies against GNL3, which are often less abundant than those for mammalian models. Researchers could address this by generating custom antibodies against Xenopus GNL3 or by creating epitope-tagged transgenic lines using the REMI technique . Additionally, while transgenic approaches in Xenopus are well-established, temporal control over gene expression can be challenging. Implementing inducible systems (e.g., Tet-On/Off or heat-shock promoters) would enable more precise investigation of stage-specific GNL3 functions, particularly during metamorphosis when significant tissue remodeling occurs.

Finally, the limited integration of multi-omics approaches represents a gap in current Xenopus GNL3 research. Future studies should combine transcriptomics, proteomics, and chromatin immunoprecipitation sequencing (ChIP-seq) to comprehensively map GNL3's regulatory networks and identify direct vs. indirect effects on target genes and cellular processes.

How can advanced genomic technologies enhance our understanding of GNL3 regulation in Xenopus development?

Advanced genomic technologies offer powerful approaches to deepen our understanding of GNL3 regulation in Xenopus development. Single-cell RNA sequencing (scRNA-seq) applied to developing Xenopus embryos can provide unprecedented resolution of GNL3 expression dynamics across different cell types and developmental stages. This approach would reveal whether GNL3 marks specific progenitor populations and how its expression correlates with cell fate decisions and differentiation states. Combined with lineage tracing techniques, this could establish causal relationships between GNL3-expressing cells and their developmental trajectories.

Chromatin accessibility assays such as ATAC-seq (Assay for Transposase-Accessible Chromatin with sequencing) can identify regulatory elements controlling GNL3 expression in different tissues. When integrated with ChIP-seq data for transcription factors and histone modifications, these approaches would construct comprehensive regulatory networks governing GNL3 transcription during development. For post-transcriptional regulation, CLIP-seq (Cross-linking immunoprecipitation followed by sequencing) could identify RNA-binding proteins that interact with GNL3 transcripts, potentially revealing mechanisms that fine-tune its expression in different cellular contexts.

Emerging genome engineering technologies like prime editing or base editing would enable precise introduction of specific mutations to study structure-function relationships in endogenous GNL3. Additionally, spatial transcriptomics techniques could map GNL3 expression patterns with subcellular resolution while preserving tissue architecture, providing context for understanding its function in complex developmental processes like organogenesis and metamorphosis.

What potential therapeutic applications might emerge from studying GNL3 in Xenopus laevis regenerative processes?

Studying GNL3 in Xenopus laevis regenerative processes could yield significant therapeutic applications with broad implications for regenerative medicine. Xenopus tadpoles exhibit remarkable regenerative capabilities, particularly in structures like the tail, limb buds, and certain neural tissues. Given GNL3's established role in regulating cell proliferation and its importance for regeneration in other organisms , understanding its specific contributions to Xenopus regeneration could identify conserved molecular mechanisms applicable to human therapeutic development.

Potential applications include identifying small molecules or gene therapy approaches that modulate GNL3 activity to enhance regenerative capacity in mammalian tissues. For instance, if research demonstrates that GNL3 coordinates the proliferative response of specific progenitor populations during Xenopus tail regeneration, similar cell types in mammals might be targeted to improve wound healing or tissue replacement. The amphibian model offers particular advantages for studying regeneration in the context of a functional immune system that shares fundamental similarities with mammals , making findings potentially more translatable than those from invertebrate models.

Furthermore, understanding how GNL3 interacts with immune cells during regeneration could inform immunomodulatory approaches to create permissive environments for tissue repair. This intersection of regenerative biology and immunology is particularly relevant for developing treatments for conditions where immune responses inhibit optimal healing, such as spinal cord injuries or chronic wounds. By leveraging the evolutionary position of Xenopus between aquatic vertebrates and mammals , research on GNL3's regenerative functions could bridge fundamental discoveries to practical therapeutic innovations.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.